REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 82 filers reported holding REPROS THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $14,721,000 | -25.5% | 850,942 | -23.6% | 0.29% | -17.9% |
| Q1 2014 | $19,771,000 | -29.9% | 1,114,462 | -27.6% | 0.36% | -36.9% |
| Q4 2013 | $28,184,000 | +39.0% | 1,540,091 | +67.3% | 0.57% | +16.2% |
| Q3 2013 | $20,275,000 | -16.5% | 920,591 | -30.1% | 0.49% | -3.4% |
| Q2 2013 | $24,287,000 | +146.1% | 1,316,357 | +114.8% | 0.50% | +54.4% |
| Q1 2013 | $9,868,000 | – | 612,906 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,132,367 | $11,210,000 | 4.33% |
| DESTRIER CAPITAL MANAGEMENT LLC | 933,600 | $9,243,000 | 2.32% |
| SENZAR ASSET MANAGEMENT, LLC | 753,600 | $7,460,000 | 2.19% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,014,164 | $10,040,000 | 1.39% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 775,307 | $7,675,000 | 0.50% |
| Trellus Management Company, LLC | 50,000 | $495,000 | 0.42% |
| FNY Managed Accounts LLC | 14,000 | $138,600,000 | 0.42% |
| GENERAL AMERICAN INVESTORS CO INC | 449,475 | $4,450,000 | 0.36% |
| Baker Brothers Advisors | 2,778,654 | $27,509,000 | 0.35% |
| CQS Cayman LP | 550,000 | $5,445,000 | 0.32% |